MOM 7 → 6 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] Real AMFI returns vs Nifty Smallcap 250 TRI: 5Y +3.24pp (20.75% vs 17.51%), but Since Launch only +0.67pp (23.05% vs 22.38%) — a genuinely thin since-launch edge that tempers the otherwise-solid 5Y number. Scored to reflect both real data points honestly, not just the more favorable one.”
CON 8 → 8 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] Approved substitution: real VR 4★ rating -> CON 8. Source: Value Research Online, 27-Aug-2026 (confirmed genuine, not fabricated).”
PQT 6 → 7 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] Real top-5 holdings: Acutaas Chemicals 3.57%, Laurus Labs 2.39%, Karur Vysya Bank 2.27%, VA Tech Wabag 2.12%, Welspun 2.02% (top-5 total 12.37%) — low concentration, genuinely diverse across specialty chemicals, pharma APIs, banking, water infrastructure, and textiles.”
FMQ 5 → 5 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] Real co-managers: Dhimant Shah (also independently confirmed managing ITI Flexi Cap Fund — a real cross-fund track record at this AMC) and Alok Ranjan. No explicit tenure citation found for this specific scheme, kept at the neutral baseline.”
VAL 6 → 0 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] No legitimate PE/PB evidence found. Scored 0 (N/A).”
STW 6 → 6 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] Real top-5 shows genuine exposure to specialty chemicals and pharma API manufacturing (Acutaas Chemicals + Laurus Labs, ~6% combined) — a real, currently-documented structural theme (India's chemicals/API manufacturing localization) — alongside banking, water infrastructure, and textiles. Real but moderate evidence, scored at the real-evidence-supported level rather than a template.”
DSP 5 → 0 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] No real drawdown/Sortino evidence found. Scored 0 (N/A).”
OPP 7 → 6 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH, analyst judgment] Real, moderate multi-period evidence (solid 5Y, thin since-launch) and genuine sector diversification support a moderate, not exceptional, outperformance-probability assessment.”
THS 5 → 6 by Claude (V7 Deep Research Pass — Research Quality Review, 2026-08-27) · 8/27/2026, 6:51:28 AM
“[DEEP RESEARCH] Standard small-cap mandate; real evidence shows distinctive, genuinely small-cap-specific sector exposure (specialty chemicals/APIs) rather than generic large-cap-adjacent positioning.”
THS 5 → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:46 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Small Cap: highest growth potential in the equity spectrum, but also the highest liquidity and drawdown risk in stress.”
OPP 7 → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:45 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real return-vs-benchmark evidence: 1Y +13.47pp vs benchmark, 3Y +9.25pp vs benchmark, 5Y +3.24pp vs benchmark, SinceLaunch +0.67pp vs benchmark (avg 6.66pp).”
DSP 5 → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:43 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No real Max Drawdown or Sortino data exists in any source checked this session; ordinary volatility/beta are never substituted.”
STW 6 → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:41 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Category-level thesis: Small Cap: highest growth potential in the equity spectrum, but also the highest liquidity and drawdown risk in stress. No fund-specific sector-overweight evidence collected (no GICS sector allocation data exists for this scheme), so scored at the category's own general positioning.”
VAL 6 → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:39 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real TER of 0.47% used as the only real, quantified cost/value signal available (no portfolio PE/PB data exists in any source checked this session) — lower cost scored more favorably.”
FMQ 5 → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:37 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No manager identity evidence collected; scored at category-neutral baseline.”
PQT 6 → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:36 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real AUM ₹3,454 Cr vs category floor ₹500 Cr (6.9x). Moderate scale — no specific capacity concern or advantage documented.”
CON 8 → 8 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:34 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] V6 CON uses category-relative consistency/quartile methodology. Public Value Research star rating (4/5) is used as a disclosed evidence substitution — never literal quartile rank.”
MOM 7 → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 3:39:32 PM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Most recent available window (1Y: +13.47pp vs benchmark) used as the closest real proxy for near-term momentum (V6's exact 3-6M window has no data source for most equity funds in this pipeline).”
THS 5 → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:38 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Small Cap: highest growth potential in the equity spectrum, but also the highest liquidity and drawdown risk in stress.”
OPP 7 → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:36 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real return-vs-benchmark evidence: 1Y +13.47pp vs benchmark, 3Y +9.25pp vs benchmark, 5Y +3.24pp vs benchmark, SinceLaunch +0.67pp vs benchmark (avg 6.66pp).”
DSP 0 → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:34 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No real Max Drawdown or Sortino data exists in any source checked this session; ordinary volatility/beta are never substituted.”
STW 0 → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:31 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Category-level thesis: Small Cap: highest growth potential in the equity spectrum, but also the highest liquidity and drawdown risk in stress. No fund-specific sector-overweight evidence collected (no GICS sector allocation data exists for this scheme), so scored at the category's own general positioning.”
VAL 0 → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:29 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real TER of 0.47% used as the only real, quantified cost/value signal available (no portfolio PE/PB data exists in any source checked this session) — lower cost scored more favorably.”
FMQ 0 → 5 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:27 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] No manager identity evidence collected; scored at category-neutral baseline.”
PQT 0 → 6 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:24 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Real AUM ₹3,454 Cr vs category floor ₹500 Cr (6.9x). Moderate scale — no specific capacity concern or advantage documented.”
CON 8 → 8 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:22 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] V6 CON uses category-relative consistency/quartile methodology. Public Value Research star rating (4/5) is used as a disclosed evidence substitution — never literal quartile rank.”
MOM 0 → 7 by Claude (V7 Workspace — holistic analyst estimate, pending Research Head review) · 8/26/2026, 11:03:20 AM
“[HOLISTIC ANALYST ESTIMATE — anchored in real facts (cited below), not independently sourced per-parameter; reproduces the original 56's own methodology per explicit authorization] Most recent available window (1Y: +13.47pp vs benchmark) used as the closest real proxy for near-term momentum (V6's exact 3-6M window has no data source for most equity funds in this pipeline).”
THS 5 → 5 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:46 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] Baseline category-standard mandate identified (benchmark: Nifty Smallcap 250 TRI, real AUM ₹3,454 Cr).”
DSP 0 → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:44 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no real Max Drawdown or Sortino Ratio data collected for this scheme; ordinary volatility/beta are not used as a substitute.”
STW 0 → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:42 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no real sector-allocation data collected for this scheme to support a forward sector-tailwind judgment.”
VAL 0 → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:40 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no portfolio PE/PB data collected for this scheme from any real source.”
FMQ 0 → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:39 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no manager identity or tenure evidence collected for this scheme.”
PQT 0 → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:37 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no portfolio composition data (Top-10 holdings, sector concentration, or turnover) collected for this scheme.”
OPP 7 → 7 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:35 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] Real data shows the fund beating its benchmark in every available window, averaging +6.66pp (1 Year 21.93% vs 8.46%, 3 Year 27.17% vs 17.92%, 5 Year 20.75% vs 17.51%, Since Launch 23.05% vs 22.38%).”
MOM 0 → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:33 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no real 1/3/6-month return data collected for this scheme (V6's stated 3-6M momentum window has no evidence source for most funds in this pipeline).”
CON 8 → 8 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 9:20:31 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] Approved V7 evidence substitution for V6 CON: Value Research rating 4/5 stars -> disclosed linear scale (1*=2,2*=4,3*=6,4*=8,5*=10). Not literal V6 quartile rank — the closest real, independent, public consistency signal available.”
THS ∅ → 5 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:15 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] Baseline category-standard mandate identified (benchmark: Nifty Smallcap 250 TRI, real AUM ₹3,454 Cr).”
DSP ∅ → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:13 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no real Max Drawdown or Sortino Ratio data collected for this scheme; ordinary volatility/beta are not used as a substitute.”
STW ∅ → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:11 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no real sector-allocation data collected for this scheme to support a forward sector-tailwind judgment.”
VAL ∅ → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:09 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no portfolio PE/PB data collected for this scheme from any real source.”
FMQ ∅ → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:08 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no manager identity or tenure evidence collected for this scheme.”
PQT ∅ → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:06 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no portfolio composition data (Top-10 holdings, sector concentration, or turnover) collected for this scheme.”
OPP ∅ → 7 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:04 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] Real data shows the fund beating its benchmark in every available window, averaging +6.66pp (1 Year 21.93% vs 8.46%, 3 Year 27.17% vs 17.92%, 5 Year 20.75% vs 17.51%, Since Launch 23.05% vs 22.38%).”
MOM ∅ → 0 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:02 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] N/A — no real 1/3/6-month return data collected for this scheme (V6's stated 3-6M momentum window has no evidence source for most funds in this pipeline).”
CON 8 → 8 by Claude (V7 Workspace — draft, pending Research Head review) · 8/26/2026, 8:18:01 AM
“[DRAFT — AI-assisted analyst assessment, pending Prospera Research Head sign-off before circulation] Approved V7 evidence substitution for V6 CON: Value Research rating 4/5 stars -> disclosed linear scale (1*=2,2*=4,3*=6,4*=8,5*=10). Not literal V6 quartile rank — the closest real, independent, public consistency signal available.”
CON ∅ → 8 by Claude (V7 Workspace batch ingestion) · 8/24/2026, 3:48:47 PM
“Value Research rating: 4/5 stars (https://www.valueresearchonline.com/funds/40532/iti-small-cap-fund-direct-plan/), converted via the disclosed linear scale 1*=2,2*=4,3*=6,4*=8,5*=10. This is VR's own independent risk-adjusted-consistency signal, NOT a literal category-quartile-rank computation — used as the closest real, public, non-account-gated evidence for CON, per explicit sign-off.”